1. Home
  2. RBBN vs VNDA Comparison

RBBN vs VNDA Comparison

Compare RBBN & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

N/A

Current Price

$1.51

Market Cap

355.8M

Sector

Technology

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$3.78

Market Cap

301.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RBBN
VNDA
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
301.1M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
RBBN
VNDA
Price
$1.51
$3.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$3.08
★ $11.50
AVG Volume (30 Days)
★ 1.4M
1.0M
Earning Date
10-27-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 170.97
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $216,105,000.00
Revenue This Year
N/A
$11.98
Revenue Next Year
$5.15
$31.71
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$1.28
$3.79
52 Week High
$3.41
$9.91

Technical Indicators

Market Signals
Indicator
RBBN
VNDA
Relative Strength Index (RSI) 46.41 26.38
Support Level $1.28 N/A
Resistance Level $1.87 $5.49
Average True Range (ATR) 0.12 0.26
MACD 0.03 -0.00
Stochastic Oscillator 61.98 6.11

Price Performance

Historical Comparison
RBBN
VNDA

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: